CPHI 2026
Curi Bio is attending CPHI 2026 (Convention on Pharmaceutical Ingredients Worldwide). Request a meeting here:
Thank you for your interest in our upcoming events! If you have any questions or want to setup a meeting, please reach out to our team.
Curi Bio is attending CPHI 2026 (Convention on Pharmaceutical Ingredients Worldwide). Request a meeting here:
Curi Bio is attending Global Bio Conference 2026. Request a meeting here:
Curi Bio is attending ESC Congress 2026. Request a meeting here:
Curi Bio is attending 53rd European Muscle Conference. Request a meeting here:
Curi Bio is attending 2026 UW Center for Translational Muscle Research (CTMR) Annual Symposium. Request a meeting here:
Curi Bio is attending COST Action Summer School 2026. Request a meeting here:
Curi Bio is attending the 62nd Interagency Botulism Research Coordinating Committee Meeting. Request a meeting here:
Curi Bio is attending SPS 2026. Request a meeting here:
Curi Bio is attending iMPSS 2026. Request a meeting here:
Curi Bio is attending EASD 2026. Request a meeting here:
Curi Bio is attending WMS 2026. Request a meeting here:
Curi Bio is attending iMND Meeting 2026. Request a meeting here:
Curi Bio is attending and presenting at the SMB 2026 in Victoria BC Canada. Request a meeting here.
Curi Bio is attending and presenting at AHA BCVS 2026. Request a meeting with Nelsa Estrella here.
Curi Bio is attending ICNMD 2026 in Florence, Italy. Request a meeting with Hamed Ghazizadeh here.
Curi BIo will be attending ESTIV 2026. Request a meeting with Mohammad Khoonkari here.
Schedule a meeting with the Curi Bio Team in Denmark. Request a meeting with Hamed and Christos here.
Curi Bio will be presenting at the DTMC of 2026.
Curi Bio will be presenting at the ECM Pharmacology Congress of 2026.
Curi Bio will be presenting at the 2026 PNS Annual Meeting.
Curi Bio will be presenting at the New Directions 2026 conference.
Curi Bio will be presenting at the Bit Bio User Exchange 2026.
Curi Bio’s team will be exhibiting at MPS World Summit 2026!
Visit the team at Booth 121 and schedule an on-site demo for an exclusive look at what’s new!
Please fill out the form below to setup a meeting.
Curi Bio’s Nelsa Estrella and Byran Koci will be attending ASGCT 2026!
Visit the team at Booth #701!
Please fill out the form below to setup a meeting.
Curi Bio’s Dr. Hamed Ghazizadeh will be attending ISCT 2026!
Please fill out the form below to setup a meeting.
Curi Bio’s Dr. Mohammad Khoonkari will be attending Olympiad in Cardiovascular Medicine 2026!
Please fill out the form below to setup a meeting.
Curi Bio’s Korea team will be attending Bio Korea 2026!
Please fill out the form below to setup a meeting.
Curi Bio is heading to Finland!
The Curi Bio team, Hamed Ghazizadeh and Mohammad Khoonkari will be in Helsinki, Finland from April 24th – 27th.
Hamed Ghazizadeh
Mohammad Khoonkari
Please fill out the form below to setup a meeting.
Curi Bio’s CBO and Co-founder, Elliot Fisher, will be presenting at Life Science Innovation Northwest 2026!
Please fill out the form below to setup a meeting.
Curi Bio is heading to Germany!
The Curi Bio team, Hamed Ghazizadeh and Mohammad Khoonkari will be in South Germany and in Berlin from April 20th – 24th.
Hamed Ghazizadeh
Mohammad Khoonkari
Please fill out the form below to setup a meeting.
The Neuromuscular Junction (NMJ) is the critical electrophysiological interface between motor neurons and skeletal muscle, and its proper function is vital to human health. Functional disruptions at this synapse are central to debilitating genetic diseases like ALS, SMA, and Myasthenia Gravis, as well as the effects of life-threatening neurotoxins. Historically, researchers have had to choose between animal models which are limited by species-specific physiology and simplified 2D cultures that lack the structural and functional complexity of human tissues. This persistent translational gap has slowed therapeutic discovery and limited the reliability of potency testing.
In this webinar, Curi Bio introduces a human 3D engineered neuromuscular junction platform designed to overcome these limitations. Built on the Mantarray™ ecosystem, this human-relevant system integrates iPSC-derived motor neuron neurospheres with 3D engineered skeletal muscle tissues in a scalable 24-well format. The platform enables rapid assembly of functional neuromuscular co-cultures within approximately 3 weeks, making advanced tissue models accessible without specialized tissue-engineering expertise.
We will delve into the technical innovations driving this platform, including:
Optogenetic Functional Sensing: How blue-light activation of motor neurons enables real-time, specific measurement of synaptic transmission and neuron-mediated muscle contraction.
Structural Maturity: Evidence from immunohistochemistry showing in mature morphology, including co-localization of axons, myotubes, and acetylcholine receptors.
Innervation-Driven Maturation: RNA-seq transcriptomics and force-frequency data demonstrating that innervation drives advanced skeletal muscle maturity and MyHC isoform shifts.
High-Throughput Potency Assays: Validation of the system as a robust, ethical alternative to animal lethality tests, with Botulinum neurotoxin (BoNT) potency measurements showing superior sensitivity and minimal variability.
Flexible Disease Modeling: Lentiviral delivery of Channelrhodopsin-2 enables rapid integration of diverse motor neuron cell lines, facilitating scalable modeling of neuromuscular diseases such as ALS and SMA.
Join Dr. Jacob W. Fleming and Dr. Thomas Leahy to learn how you can leverage these advanced 3D neuromuscular junction models to generate decision-driving data for your research and therapeutic discovery pipelines.
Wednesday, April 15, 2026 at 8:00-9:00am PDT (11:00am EDT / 5:00pm CEST)
Curi Bio is heading to Denmark and Sweden!
The Curi Bio team, Hamed Ghazizadeh, Christos Michas, and Travis Moerk will be in Denmark and Sweden from April 7th – 9th.
Hamed Ghazizadeh
Christos Michas
Travis Moerk
Please fill out the form below to setup a meeting.
Curi Bio’s Dr. Greg Luerman will be presenting at the ORS 2026 Annual Meeting!
Please fill out the form below to setup a meeting with a Curi Bio team member.
Curi Bio’s Dr. Hamed Ghazizadeh and Dr. Mohammad Khoonkari will be sponsoring and presenting at the Lama-2 Conference 2026!
Please fill out the form below to setup a meeting with a Curi Bio team member.
Curi Bio’s Dr. Nicholas Geisse will be presenting at the 2026 Next-Wave Obesity Therapeutics & Drug Development Summit Europe Meeting!
Please fill out the form below to setup a meeting with Dr. Geisse in Barcelona.
Curi Bio team members, Dr. Nicholas Geisse, Elliot Fisher, Bryan Koci, and Dr. Christal Worthen, will be exhibiting at the 2026 SOT Annual Meeting!
Please fill out the form below to setup a meeting with a Curi Bio team member.
In this free live webinar, we will cover:
Human-Relevant Maturity: Learn how 3D bioengineered tissues reach a stable, adult-like metabolic and structural state by day 21.
Predictive Metabolic Function: Explore breakthroughs in capturing robust insulin-stimulated glucose uptake and mature GLUT4 localization for diabetes research.
Exercise Physiology In Vitro: See how exercise-mimicking stimulation and detraining mirror real-world human muscle plasticity and reversibility.
New Biological Insights: Discover the role of GYS1 and glycogen metabolism in sustaining muscle endurance under metabolic stress.
Join this webinar for the opportunity to learn more and join the live Q&A.
The translational gap between animal models and human clinical outcomes often stems from fundamental interspecies differences in fiber composition and metabolic regulation. This webinar features a landmark study from Novo Nordisk and the University of Copenhagen, utilizing Curi Bio’s Mantarray 3D skeletal muscle ecosystem.
We will detail a comprehensive workflow for generating functionally mature human muscle tissues that stabilize for longitudinal study. By integrating physiological, pharmacological, and genetic perturbations, the research team demonstrated that these tissues not only mirror human-like responses to insulin and exercise but also reveal new mechanisms of metabolic resilience. This session will provide a roadmap for using New Approach Methodologies (NAMs) to advance drug discovery for obesity, diabetes, and neuromuscular diseases.
Wednesday, March 18, 2026 at 8:00-9:00am PT (11:00am ET / 5:00pm CET)
Curi Bio is heading to London! 💂
Our Business Development team, Hamed Ghazizadeh and Mohammad Khoonkari will be in London from March 16th – 20th. At Curi Bio, we believe that world-class science deserves a personalized, white-glove approach to partnership.
Hamed Ghazizadeh
Mohammad Khoonkari
While Hamed connects with the community at the Advanced Therapies conference, Mohammad will be visiting with local partners throughout the city. They are both available for 1:1 sessions and technical consultations to discuss how Curi Bio’s 3D human-relevant discovery platforms are redefining the path to the clinic.
Whether you’re interested in a deep dive into our Mantarray™ platform for 3D muscle contractility or exploring our full end-to-end ecosystem of cells and AI-driven analytics, we want to hear about your specific drug discovery goals.
Let’s bridge the gap between bench top discovery and clinical potential together.
Are you based in London or attending Advanced Therapies?
Please fill out the form below to setup a meeting.
Curi Bio team members, Dr. Hamed Ghazizadeh and Dr. Mohammad Khoonkari, will be at the Dutch-German Joint Meeting in Amsterdam! Come visit us at our booth and meet with Hamed Ghazizadeh and Mohammed Khoonkari to explore our scalable solutions for cardiovascular research. Plus, don't miss our sponsored talk on Friday, March 13th!
Please fill out the form below to setup a meeting with a Curi Bio team member.
Curi Bio team members, Dr. Nicholas Geisse, Elliot Fisher, Dr. Nelsa Estrella, Dr. Christal Worthen, and Dr. Greg Luerman, will be at MDA 2026 in Orlando, FL!
Oral Presentation
Title: Beyond 2D: Utilizing Curi Bio’s 3D Engineered Muscle Tissue for Predictive Disease Modeling
Presented By: Dr. Nicholas Geisse
March 9, 4-6p, Orange ABC
Poster Presentation
Title: Dystrophin Deficiency Attenuates Fibroadipogenic Progenitor–Mediated Contractile Maturation in 3D Engineered Muscle Tissues
Poster Presentation
Title: Modeling MYBPC3-Driven Hypertrophic Cardiomyopathy Using Human 3D Engineered Heart Tissues
Poster Presentation
Title: Innervation Induces a Distinct Force–Frequency Phenotype in 3D Human Neuromuscular Junction Tissues
Please fill out the form below to setup a meeting with a Curi Bio team member at MDA 2026.
Curi Bio is proud to participate in the 27th NIH Tissue Chip Consortium Meeting & C-Path Public Workshop at the National Cancer Institute. We’ll be in the DC area from Thursday through Saturday, connecting the dots between our mission, providing human data for next-generation medicines, and the critical regulatory frameworks being established by the NIH and C-Path’s Predictive Safety Testing Consortium.
Our CEO, Nicholas Geisse, will be a featured speaker at the event! He will be speaking on Day 1 (March 5). Nicholas will be presenting on Curi Bio’s BoNT (Botulinum Neurotoxin) assay, showcasing how our 3D Neuromuscular Junction (NMJ) models are advancing functional, human-relevant safety and efficacy testing.
Our CBO, Elliot Fisher, will also be attending and ready to discuss how our 3D ecosystems and workflow are helping partners reduce preclinical risk to make data-driven "Go/No-Go" decisions sooner, maximizing the impact of your R&D investment.
Day 1 (March 5): Defining "Context of Use" and evidentiary standards, essential steps for making Microphysiological Systems (MPS) a regulatory standard.
Day 2 (March 6): The integration of In-Silico NAMs and tissue chips, the powerful synergy that is reshaping the industry.
🤝 Let's Connect! Please fill out the form below to request a meeting with Nick and/or Elliot.